Prospective meta-analysis protocol on randomised trials of renin–angiotensin system inhibitors in patients with COVID-19: an initiative of the International Society of Hypertension

INTRODUCTION: Whether ACE inhibitors (ACEi) or angiotensin II receptor blocker (ARB) therapy should be continued, initiated or ceased in patients with COVID-19 is uncertain. Given the widespread use of ACEi/ARBs worldwide, guidance on the use of these drugs is urgently needed. This prospective meta-...

Descripción completa

Detalles Bibliográficos
Autores principales: Gnanenthiran, Sonali Rukshana, Borghi, Claudio, Burger, Dylan, Charchar, Fadi, Poulter, Neil R, Schlaich, Markus P, Steckelings, Ulrike Muscha, Stergiou, George, Tomaszewski, Maciej, Unger, Thomas, Wainford, Richard D, Williams, Bryan, Rodgers, Anthony, Schutte, Aletta E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887864/
https://www.ncbi.nlm.nih.gov/pubmed/33593784
http://dx.doi.org/10.1136/bmjopen-2020-043625

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887864/
https://www.ncbi.nlm.nih.gov/pubmed/33593784
http://dx.doi.org/10.1136/bmjopen-2020-043625

Ejemplares similares